JAK3 and juvenile myelomonocytic leukemia: Transformation to AML was seen in 2 of the 18 patients with JMML (11%) patients, both harboring somatic KRAS mutations and one with acquired sub clonal somatic mutations in PTPN11, JAK3, TERT, and CBL.